๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma

โœ Scribed by Shohachi Suzuki; Takanori Sakaguchi; Yoshihiro Yokoi; Kazuya Okamoto; Kiyotaka Kurachi; Yasuo Tsuchiya; Takuya Okumura; Hiroyuki Konno; Satoshi Baba; Satoshi Nakamura

Publisher
Springer
Year
2002
Tongue
English
Weight
746 KB
Volume
26
Category
Article
ISSN
0364-2313

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Clinicopathologic spectrum of resected e
Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma
โœ Naoki Yamanaka; Eizo Okamoto; Tatsuya Ando; Takeshi Oriyama; Jiro Fujimoto; Kazu ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 900 KB

## Background: The mode of tumor growth of intrahepatic cholangiocarcinoma (cc) varies considerably from patient to patient. this study describes the clinicopathologic variety of the extraductal mass-forming type of cc. ## Methods: Patients with cc characterized by an extraductal mass (n = 26) wh

Prognostic factors of resectable intrahe
Prognostic factors of resectable intrahepatic cholangiocarcinoma
โœ Fong-Fu Chou; Shyr-Ming Sheen-Chen; Chao-Long Chen; Yaw-Sen Chen; Mao-Chan Chen ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 474 KB

## ~ ~ Intrahepatic cholangiocarcinoma is a rare disease. The prognostic factors of resectable cholangiocarcinoma have not been previously reported. Nineteen patients (lOM, 9F) with resectable cholangiocarcinoma were investigated to find factors that might influence prognosis. The cumulative surv

MUC4 is a novel prognostic factor of int
MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type
โœ Hiroaki Shibahara; Shugo Tamada; Michiyo Higashi; Masamichi Goto; Surinder K. Ba ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 392 KB

Complete surgical resection of the tumor is the sole approach to improve the cure rate of patients with intrahepatic cholangiocarcinoma-mass forming type (ICC-MF). Although patients are treated by curative resection, many of them show poor outcome. Mucin (MUC)4 expression has been implicated as a ma